ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 86

Auxilin Is a Novel Susceptibility Gene for Congenital Heart Block Modulating Cardiac Function

Sabrina Meisgen1, Malin Hedlund1, Aurélie Ambrosi1, Lasse Folkersen2, Vijole Dzikaite-Ottosson3, Bo Ding1, Linn Strandberg4, Luca Biavati4, Daniel Ramsköld5, David Forsberg1, Lisa Bergin1, Sabrina Ruhrmann1, The Swedish Congenital Heart Block Study Group1, Robert M. Hamilton6, Anders Franco-Cereceda1, Anders Hamsten1, Tomas Olsson7, Lois Greene8, Per Eriksson1, Kristina Gemzell-Danielsson1, Stina Salomonsson1, Vijay K. Kuchroo9, Eric Herlenius1, Ingrid Kockum7, Sven-Erik Sonesson1 and Marie Wahren-Herlenius10, 1Karolinska Institutet, Stockholm, Sweden, 2Technical University of Denmark, Copenhagen, Denmark, 3Department of Medicine, Rheumatology Unit, Centre for Molecular Medicine (CMM), Karolinska Institutet, Stockholm, Sweden, 4Hospital for Sick Children Toronto, Toronto, ON, Canada, 5Department of Medicine, Rheumatology Unit, Karolinska Institutet, Stockholm, Sweden, 6Cardiology, The Hospital for Sick Children, University of Toronto, Toronto, ON, Canada, 7Neuroimmunology, Department of Clinical Neurosciences, Karolinska Institutet, Stockholm, Sweden, 8National Heart, Lung and Blood Institute, Bethesda, MD, 9Center of Neurological Disease, Harvard Medical School, Boston, MA, 10Department of medicine, Rheumatology unit, Karolinska Institutet, Stockholm, Sweden

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: GWAS, Sjogren's syndrome and neonatal lupus

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 8, 2015

Title: Genetics, Genomics and Proteomics Poster I

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose:

Congenital heart block (CHB) may affect children of women with anti-Ro/SSA and anti-La/SSB autoantibodies. The most recognized manifestation of CHB is an atrioventricular (AV) block, but atrial and ventricular arrhythmias, a prolonged isovolumetric contraction time and cardiomyopathies also affect a substantial proportion of the babies. The potentially lethal cardiac manifestations develop in utero during gestational weeks 18-24, and the risk of giving birth to a child with CHB is 1-2% in anti-Ro/SSA-positive pregnancies. A recurrence rate of only 12% despite persisting maternal autoantibodies suggests that additional factors influence disease development. The purpose of this study was to identify fetal genetic susceptibility factors for CHB, and to understand their functional impact on pathogenesis.

Methods:

We performed a genome-wide association study of >500,000 single nucleotide polymorphisms (SNP) in a population-based cohort of families with children diagnosed with CHB and analyzed transmission of SNPs based on genotypes of index cases (n=92) and first degree relatives (n=256). CHB-associated SNPs (p≤ 1×10-4) were replicated in a population-based case-control analysis (ncontrols=1122). Expression quantitative trait loci (eQTL) analysis was performed in cardiac tissue of genes present in the regions surrounding replicating SNPs (±500 kb) across both data sets. Human and mouse tissue expression of genes and proteins was assessed by qPCR, RNAseq, Western blot, immunohistochemistry and immunofluorescence staining. Functional analysis in vitro using primary cultured cardiomyoctes from genetically modified neonatal mouse pups was performed with time lapse Ca2+ recordings. Doppler echocardiography was used to assess cardiac disease phenotypes in utero.

Results: We discovered DNAJC6 as a novel fetal susceptibility gene associated with CHB, with decreased cardiac expression of DNAJC6 associated with the disease risk genotype. Auxilin, the putative tyrosine-protein phosphatase encoded by DNAJC6, was remarkably higher expressed in the fetal compared to the adult heart both before and during the risk period for CHB (>10 fold, p< 0.001). In human fetal cardiomyocytes we observed auxilin in the cytoplasm in a vesicular pattern, co-localized with clathrin, suggesting that the cellular function of auxilin in cardiomyocytes, as already described for neurons, is within the clathrin-mediated endocytic process. Analysis of auxilin-deficient cardiomyocytes of neonatal mice revealed abnormal connectivity and Ca2+ homeostasis in culture. Doppler echocardiography of auxilin-deficient fetal mice in utero revealed several CHB-related manifestations in vivo, including AV-block, abnormal heart rhythm with atrial and ventricular ectopias and a prolonged isovolumetric contraction time as a sign of decreased myocardial performance.

Conclusion:

In conclusion, our study identifies auxilin as the first susceptibility gene in CHB modulating cardiac function, and connects the decreased auxilin expression observed for the susceptibility allele with clinical fetal CHB features.


Disclosure: S. Meisgen, None; M. Hedlund, None; A. Ambrosi, None; L. Folkersen, None; V. Dzikaite-Ottosson, None; B. Ding, None; L. Strandberg, None; L. Biavati, None; D. Ramsköld, None; D. Forsberg, None; L. Bergin, None; S. Ruhrmann, None; T. S. C. H. B. Study Group, None; R. M. Hamilton, None; A. Franco-Cereceda, None; A. Hamsten, None; T. Olsson, None; L. Greene, None; P. Eriksson, None; K. Gemzell-Danielsson, None; S. Salomonsson, None; V. K. Kuchroo, None; E. Herlenius, None; I. Kockum, None; S. E. Sonesson, None; M. Wahren-Herlenius, None.

To cite this abstract in AMA style:

Meisgen S, Hedlund M, Ambrosi A, Folkersen L, Dzikaite-Ottosson V, Ding B, Strandberg L, Biavati L, Ramsköld D, Forsberg D, Bergin L, Ruhrmann S, Study Group TSCHB, Hamilton RM, Franco-Cereceda A, Hamsten A, Olsson T, Greene L, Eriksson P, Gemzell-Danielsson K, Salomonsson S, Kuchroo VK, Herlenius E, Kockum I, Sonesson SE, Wahren-Herlenius M. Auxilin Is a Novel Susceptibility Gene for Congenital Heart Block Modulating Cardiac Function [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/auxilin-is-a-novel-susceptibility-gene-for-congenital-heart-block-modulating-cardiac-function/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/auxilin-is-a-novel-susceptibility-gene-for-congenital-heart-block-modulating-cardiac-function/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology